The Medicare and Medicare Advantage programs that reimburse doctors and hospitals for drugs and devices were once billed as providing high-quality care.
But since 2008, the Medicare spending on prescription drugs has more than doubled, according to the Congressional Budget Office.
That means Medicare is spending more money on the same drugs than it is on the drugs it already reimburses hospitals for.
That has created a problem: the Medicare program doesn’t make enough money to cover the cost of medicines, and the price of drugs and the cost to administer the drugs have soared.
This has created an imbalance in the drug market, says Dr. Kevin M. Schatz, chief medical officer at the Kaiser Family Foundation.
“It’s a real problem,” says Schatz.
“When you’re dealing with an imbalance, it’s really hard to get a steady balance.”
The problem is compounded by a huge increase in the costs of drugs over the past decade.
In fiscal year 2014, Medicare spent $821 billion on prescription drug costs.
In 2015, that figure jumped to $923 billion.
Medicare spends more on drugs than on all of the federal and state governments combined.
That’s because the Medicare drug benefit, which provides drug benefits to Medicare beneficiaries, includes more than just prescription drugs.
In order to be eligible for benefits, Medicare recipients have to pay for their drugs.
But because prescription drugs are typically prescribed by doctors, the benefit is not shared equally among all doctors.
That creates a huge incentive for doctors to prescribe the drugs at the highest prices.
That makes it difficult for Medicare to fund its own prescription drug program.
That problem was compounded by an explosion in the cost and availability of new drugs over recent years.
“We are going through a boom, and that is the most significant change in the prescription drug market in my career,” says Dr., Dr. David R. Foskett, professor of medicine and public health at Columbia University Medical Center.
“If you look at the trends over the last decade, the cost has gone up dramatically and there has been a tremendous increase in generics.
The generics have been expensive.
The cost of generic drugs has increased more than 90 percent.
They’re very expensive.
That is a major problem for the Medicare and other drug benefit programs.”
Some Medicare programs have had to increase their payments for drugs.
“As of March 31, 2014, [Medicare] had spent $1.6 billion more than it was spending on generic drugs,” says the CBA’s Schatz and Medicare’s Haney.
“This represents the largest increase in Medicare spending for prescription drugs in its history.”
In 2016, the CCA released a report detailing the growing problems with Medicare’s drug plan.
The CCA estimates that Medicare’s prescription drug benefit will have to increase by nearly $4 billion by 2026.
This increase in spending could mean the program’s costs for drugs are increasing by at least $1,000 a month, and by as much as $2,000.
And that’s not counting the increase in out-of-pocket costs Medicare will have had this year.
And Medicare’s cost to pay physicians will increase by $1 billion, as well.
That could have a big impact on physicians’ budgets.
“There are a lot of people who are struggling to make ends meet,” says Robert J. Saylor, professor at the Johns Hopkins University School of Medicine.
“And the drug benefit program has become the largest contributor to that.
So we will continue to see an increase in costs for Medicare as a result of this.”
It’s a problem that affects a wide range of providers, but most doctors say they don’t see the increase as a problem.
The most common complaint from doctors is that the Medicare prescription drug benefits are too low.
“The cost is so high that there is no incentive to be reimbursed for these drugs,” said Fosks, who adds that Medicare doesn’t cover drugs that cost more than $100 a month.
“In the long run, it will probably mean that the people who have to work hard are not reimbursed, and it will mean that some of the doctors that do have the best incentives to work harder are not paid enough for their services.”
“I have to be honest,” says R. David Haney, professor emeritus of medicine at Columbia.
“I don’t know what it is that I see as the root of it.
I don’t have a crystal ball.
But I do know that this has become a very serious issue.”
In addition to the increased costs of the drugs, some doctors say the program is being used as a means of pushing down the cost for prescription drug coverage.
The Centers for Medicare and Medigap Services says that since the inception of the program, there has only been a 10 percent decrease in the number of Medicare beneficiaries enrolled in coverage.
“With the advent of the prescription program, that has declined to about 4 percent, which is still a pretty high